Nasdaq
$135.07▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $10.18BShares out 75.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
28- 9.14Pre-market26.09.14 19:0115-12GOther#●●●
Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. has filed Form 15 to terminate the registration of its common stock and suspend its reporting obligations under Section 12(g) of the Securities Exchange Act. The company reports that there is currently only one holder of record, effectively ending its requirement to file periodic reports with the SEC.…more
$135.07+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.8After-hours26.09.09 06:08SCHEDULE 13D/AOwnership
Apogee Therapeutics, Inc.
Key investors associated with Venrock at Apogee Therapeutics have filed Powers of Attorney and a Joint Filing Agreement with the SEC. This action establishes the administrative framework for the coordinated reporting of their holdings and future transactions.…more
$135.07+0.00%vs prev closeView filingShare - 9.3After-hours26.09.04 06:31SCHEDULE 13D/AOwnership
Apogee Therapeutics, Inc.
Fairmount Funds Management LLC has filed a SCHEDULE 13D/A regarding its beneficial ownership in Apogee Therapeutics, Inc. This filing serves to formally update the status of the major shareholder's equity position.…more
$135.07+0.00%vs prev closeView filingShare
27 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.10Pre-market26.08.10 20:00Bullish#●●●#●●●
애브비, 아포지 테라퓨틱스 109억 달러에 인수
애브비가 아포지 테라퓨틱스를 주당 135.11달러, 총 109억 달러 규모로 인수하기로 합의했습니다. 이번 인수는 아포지의 면역학 파이프라인을 확보하여 애브비의 포트폴리오를 강화하기 위한 전략적 결정입니다.…more
$135.07+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUS